These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 11603924

  • 1. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
    Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro RJ, Wieczorek DF.
    J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
    [Abstract] [Full Text] [Related]

  • 2. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S, Ahmed RP, Jagatheesan G, Petrashevskaya N, Boivin GP, Urboniene D, Arteaga GM, Wolska BM, Solaro RJ, Liggett SB, Wieczorek DF.
    Circ Res; 2007 Jul 20; 101(2):205-14. PubMed ID: 17556658
    [Abstract] [Full Text] [Related]

  • 3. A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.
    Prabhakar R, Petrashevskaya N, Schwartz A, Aronow B, Boivin GP, Molkentin JD, Wieczorek DF.
    Mol Cell Biochem; 2003 Sep 20; 251(1-2):33-42. PubMed ID: 14575301
    [Abstract] [Full Text] [Related]

  • 4. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC, Palmer BM, Stauffer BL, Leinwand LA, Moore RL.
    Circ Res; 2004 Feb 06; 94(2):201-7. PubMed ID: 14670849
    [Abstract] [Full Text] [Related]

  • 5. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis.
    Jagatheesan G, Rajan S, Petrashevskaya N, Schwartz A, Boivin G, Arteaga GM, Solaro RJ, Liggett SB, Wieczorek DF.
    Am J Physiol Heart Circ Physiol; 2007 Aug 06; 293(2):H949-58. PubMed ID: 17416600
    [Abstract] [Full Text] [Related]

  • 6. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D, Guzman G, Zhao J, Hernandez O, Wei J, Diaz-Perez Z.
    J Cell Sci; 2005 Aug 15; 118(Pt 16):3675-83. PubMed ID: 16076902
    [Abstract] [Full Text] [Related]

  • 7. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
    Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA.
    Circulation; 2004 Oct 12; 110(15):2102-9. PubMed ID: 15466629
    [Abstract] [Full Text] [Related]

  • 8. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay.
    Bing W, Knott A, Redwood C, Esposito G, Purcell I, Watkins H, Marston S.
    J Mol Cell Cardiol; 2000 Aug 12; 32(8):1489-98. PubMed ID: 10900175
    [Abstract] [Full Text] [Related]

  • 9. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L, Bogoyevitch MA, Seidman CE, Seidman JG, Semsarian C.
    Circulation; 2008 Apr 08; 117(14):1820-31. PubMed ID: 18362229
    [Abstract] [Full Text] [Related]

  • 10. Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.
    Bing W, Redwood CS, Purcell IF, Esposito G, Watkins H, Marston SB.
    Biochem Biophys Res Commun; 1997 Jul 30; 236(3):760-4. PubMed ID: 9245729
    [Abstract] [Full Text] [Related]

  • 11. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T, Witjas-Paalberends ER, Boontje NM, Tripathi S, Brandis A, Montag J, Hodgkinson JL, Francino A, Navarro-Lopez F, Brenner B, Stienen GJ, van der Velden J.
    J Mol Cell Cardiol; 2013 Apr 30; 57():13-22. PubMed ID: 23318932
    [Abstract] [Full Text] [Related]

  • 12. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity.
    Stefanelli CB, Rosenthal A, Borisov AB, Ensing GJ, Russell MW.
    Mol Genet Metab; 2004 Apr 30; 83(1-2):188-96. PubMed ID: 15464434
    [Abstract] [Full Text] [Related]

  • 13. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction.
    Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF.
    Circ Res; 1999 Jul 09; 85(1):47-56. PubMed ID: 10400910
    [Abstract] [Full Text] [Related]

  • 14. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
    Coutu P, Bennett CN, Favre EG, Day SM, Metzger JM.
    Circ Res; 2004 May 14; 94(9):1235-41. PubMed ID: 15059934
    [Abstract] [Full Text] [Related]

  • 15. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T, Chung J, Doolan A, Nguyen L, Williams IA, Tu E, Lam L, Bailey CG, Rasko JE, Allen DG, Semsarian C.
    J Mol Cell Cardiol; 2006 Oct 14; 41(4):623-32. PubMed ID: 16950368
    [Abstract] [Full Text] [Related]

  • 16. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y, Xu Y, Kerrick WG, Wang Y, Guzman G, Diaz-Perez Z, Szczesna-Cordary D.
    J Mol Biol; 2006 Aug 11; 361(2):286-99. PubMed ID: 16837010
    [Abstract] [Full Text] [Related]

  • 17. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
    Semsarian C, Healey MJ, Fatkin D, Giewat M, Duffy C, Seidman CE, Seidman JG.
    J Mol Cell Cardiol; 2001 Nov 11; 33(11):2055-60. PubMed ID: 11708849
    [Abstract] [Full Text] [Related]

  • 18. Autonomic cardiac control in animal models of cardiovascular diseases II. Variability analysis in transgenic rats with alpha-tropomyosin mutations Asp175Asn and Glu180Gly.
    Wernicke D, Wessel N, Malberg H, Plehm R, Bauernschmitt R, Thierfelder L.
    Biomed Tech (Berl); 2007 Feb 11; 52(1):50-5. PubMed ID: 17313334
    [Abstract] [Full Text] [Related]

  • 19. Beta-tropomyosin overexpression induces severe cardiac abnormalities.
    Muthuchamy M, Boivin GP, Grupp IL, Wieczorek DF.
    J Mol Cell Cardiol; 1998 Aug 11; 30(8):1545-57. PubMed ID: 9737941
    [Abstract] [Full Text] [Related]

  • 20. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F.
    J Am Coll Cardiol; 2011 Aug 16; 58(8):839-48. PubMed ID: 21835320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.